Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications.
Antihistamines
Class Summary
These agents are for mild-to-severe reactions.
Diphenhydramine (Benadryl, Benylin)
For symptomatic relief of symptoms caused by release of histamine in allergic reactions.
Nonsteroidal anti-inflammatory drugs
Class Summary
These agents relieve pain and reduce inflammation.
Ibuprofen (Ibuprin, Advil, Motrin)
Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Corticosteroids
Class Summary
These agents have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli. A short course may be used for severe local reactions.
Prednisone (Deltasone, Orasone, Sterapred)
May decrease inflammation by reversing increased capillary permeability and suppressing PMN activity. Many dosing regimens have been used.
Anaphylaxis treatment kit
Class Summary
This agent is used for anaphylaxis reactions.
Epinephrine (EpiPen, Adrenalin)
DOC for treating anaphylactoid reactions. Has alpha-agonist effects that include increased peripheral vascular resistance, reversed peripheral vasodilatation, systemic hypotension, and vascular permeability. Beta-agonist effects of epinephrine include bronchodilatation, chronotropic cardiac activity, and positive inotropic effects.
Hoffman DR. Ant venoms. Curr Opin Allergy Clin Immunol. Aug 2010;10(4):342-6. [Medline].
More DR, Kohlmeier RE, Hoffman DR. Fatal anaphylaxis to indoor native fire ant stings in an infant. Am J Forensic Med Pathol. Mar 2008;29(1):62-3. [Medline].
La Shell MS, Calabria CW, Quinn JM. Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study. J Allergy Clin Immunol. Jun 2010;125(6):1294-9. [Medline].
[Guideline] Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol. Oct 2004;114(4):869-86. [Medline]. [Full Text].
Williams DF, deShazo RD. Biological control of fire ants: an update on new techniques. Ann Allergy Asthma Immunol. Jul 2004;93(1):15-22. [Medline].
Burroughs R, Elston DM. What's eating you? Fire ants. Cutis. Feb 2005;75(2):85-9. [Medline].
Champion RH, Burton JL, Burns DA. Rook/Wilkinson/Ebling Textbook of Dermatology. Vol 2. 6th ed. London, England: Blackwell Science; 1998:1436-7.
Cotran RS, Kumar V, Collins T, eds. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1999:1212.
Dambro MR, Griffith JA. Griffith's 5-Minute Clinical Consult. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:570-1.
Ellis AK, Day JH. Clinical reactivity to insect stings. Curr Opin Allergy Clin Immunol. Aug 2005;5(4):349-54. [Medline].
Ford JL, Dolen WK, Feger TA, Hoffman DR, Stafford CT. Evaluation of an in vitro assay for fire ant venom-specific IgE. J Allergy Clin Immunol. Sep 1997;100(3):425-7. [Medline].
Freedberg IM, Eisen AZ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. Vol 2. 5th ed. New York, NY: McGraw-Hill; 1999:2693-5.
Goddard J, Jarratt J, de Castro FR. Evolution of the fire ant lesion. JAMA. Nov 1 2000;284(17):2162-3. [Medline].
Hoffman DR. Reactions to less common species of fire ants. J Allergy Clin Immunol. Nov 1997;100(5):679-83. [Medline].
Jerrard DA. ED management of insect stings. Am J Emerg Med. Jul 1996;14(4):429-33. [Medline].
Kemp SF, deShazo RD, Moffitt JE, Williams DF, Buhner WA. Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol. Apr 2000;105(4):683-91. [Medline].
Lee TH, Comes S, Burgos T. ePocrates qRx. ePocrates Inc. Available at http://www.epocrates.com/. Accessed 2000.
Odom RB, James WD, Berger TG. Andrews' Diseases of the Skin: Clinical Dermatology. 9th ed. Philadelphia, Pa: WB Saunders; 2000:559.
Ownby DR. Pediatric anaphylaxis, insect stings, and bites. Immunol Allergy Clin North Am. 1999;19 (2):347-61.
Rakel RE. Conn's Current Therapy 2000. 52nd ed. Philadelphia, Pa: WB Saunders; 2000:753-5.
Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. Jul 2000;43(1 Pt 1):1-16; quiz 16-8. [Medline].

